(Total Views: 257)
Posted On: 12/07/2022 12:33:18 PM
Post# of 7499
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
"These cases demonstrate that following knee and hip arthroplasty, the
use of pulsed shortwave therapy devices is feasible in both the in- and
out-patient settings and may improve analgesia while decreasing—perhaps
sometimes obviating—opioid consumption."
Full article here:
https://www.fortunejournals.com/articles/noni...series.pdf
Kelly Whelan, CEO
BioElectronics Corporation
(OTC: BIEL)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)